 By David Bautz, PhD, CFA NASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT Business Update Clinical Trial to Initiate for MN-166 in Patients with COVID-19 ARDS On April 8, 2020, MediciNova, Inc. NASDAQ:MNOV announced that a clinical trial of MN-166 ibudilast will be initiated in patients with acute respiratory distress syndrome ARDS caused by COVID-19 coronavirus disease 2019. The trial will 